GIUSEPPE DI BELLA
>
DOCUMENTATION INDEX > Patient Area - Documents
Role of retinoic acid in the modulation of benzo(a)pyrene-DNA adducts in human hepatoma cells: implications for cancer prevention.
(12/04/2011)
Detail
NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome.
(12/04/2011)
Detail
Retinoid pathway and cancer therapeutics.
(12/04/2011)
Detail
All-trans retinoic acid is capable of inducing folate receptor β expression in KG-1 cells.
(12/04/2011)
Detail
Proliferative and anti-proliferative effects of retinoic acid at doses similar to endogenous levels in Leydig MLTC-1/R2C/TM-3 cells.
(12/04/2011)
Detail
Downregulation of AKR1B10 gene expression in colorectal cancer
(12/04/2011)
Detail
Vitamins and prostate cancer risk.
(12/04/2011)
Detail
Retinol supplementation and mesothelioma incidence in workers earlier exposed to blue asbestos (Crocidolite) at Wittenoom, Western Australia.
(12/04/2011)
Detail
Vitamin D analogs.
(12/04/2011)
Detail
Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry.
(12/04/2011)
Detail
Randomized phase II trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer.
(12/04/2011)
Detail
Proteomic approach reveals novel targets for retinoic acid-mediated therapy of thyroid carcinoma.
(12/04/2011)
Detail
The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3beta pathway and beta-catenin stability.
(12/04/2011)
Detail
RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells.
(12/04/2011)
Detail
All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma.
(12/04/2011)
Detail